Not finding it? Sign in to also search OpenAlex live.
-
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler, Eva‐Maria Wagner‐Drouet, Salem Ajib, Gesine Bug, Martina Margrit Crysandt, Sabine Dressler, +19 more
70citations -
Pretransplantation Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia Patients: A Real-World Analysis from the Cooperative Transplant Study Group2025 Transplantation and Cellular Therapy article Medicine Acute Myeloid Leukemia Research Open access
Christina Rautenberg, Matthias Stelljes, Gesine Bug, Udo Holtick, Edgar Jost, Sara Jennrich, +14 more
3citations -
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler, Eva‐Maria Wagner‐Drouet, Salem Ajib, Gesine Bug, Martina Margrit Crysandt, Sabine Dressler, +19 more
1citations -
Fedratinib in combination with CC-486, an oral hypomethylating agent, in patients with accelerated phase myelofibrosis: Results from the phase I/II famy trial2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Nadja Jaekel, Susann Schulze, Christina Zahn, Andreas Wienke, Michael Richter, Steffen Koschmieder, +5 more
1citations -
Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies2023 Leukemia article Biochemistry, Genetics and Molecular Biology Epigenetics and DNA Methylation Open access cited by 2 patents
Jessie S. Kroonen, Ilona J. de Graaf, Sumit Kumar, Dennis F.G. Remst, Anne K. Wouters, Mirjam H.M. Heemskerk, +1 more
22citations -
S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY (“3 + 7”) FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP, GIMEMA, CELG, AND GMDS-SG
M Lübbert, P. W. Wijermans, Michal Kiciński, Sylvain Chantepie, Walter J. F. M. van der Velden, Richard Noppeney, +26 more
3citations -
Trial in Progress: A Randomized-Controlled Phase 2 Study Evaluating Venetoclax Plus Azacitidine Versus Intensive Chemotherapy in Adult Patients with Newly Diagnosed, NPM1-Mutated AML - the SAL/AMLCG Vincent Trial
Leo Ruhnke, Christoph Schliemann, Lars R. Fransecky, Björn Steffen, Martin Kaufmann, Andreas Burchert, +26 more
2citations -
Elevation of fetal hemoglobin is a biomarker for response to decitabine in AML: Results of the AML21 randomized phase III trial of the EORTC leukemia group, gimema and german MDS study group
Julia Stomper, Michal Kiciński, Tobias Ma, Sylvain Chantepie, Richard Noppeney, Mario Luppi, +16 more
0citations -
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer2023 Frontiers in Immunology article Medicine CAR-T cell therapy research Open access cited by 2 patents
Rosa A. van Amerongen, Sander Tuit, Anne K. Wouters, Marian van de Meent, Sterre L. Siekman, Miranda H. Meeuwsen, +9 more
25citations -
The implication of TET1, miR-200, and miR-494 expression with tumor formation in colorectal cancer: through targeting Wnt signaling2024 Molecular Biology Reports article Biochemistry, Genetics and Molecular Biology MicroRNA in disease regulation Open access
Raziye Tajali, Neda Zali, Fatemeh Naderi Noukabadi, Morteza Valinezhad, Farnaz Ghasemian, Makan Cheraghpour, +2 more
3citations -
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial
Michael Lübbert, Pierre W. Wijermans, Michal Kiciński, Sylvain Chantepie, Walter J. F. M. van der Velden, Richard Noppeney, +32 more
41citations -
Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY ‐1 and MOMENTUM Trials2026 European Journal Of Haematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Francesca Palandri, Casey Lee O'Connell, Pankit J. Vachhani, Donal P. McLornan, Steffen Koschmieder, Juan Carlos Hernández‐Boluda, +6 more
0citations